Treatment of Comorbid Anxiety in Youth with ASD
#B3-5 Treatment of Comorbid Anxiety in Youth with ASD
Autism Spectrum Disorder is a neurodevelopmental disorder affecting 1 in 59 school-age youth. In addition to the potential for significant functional impairment associated with ASD core symptoms, youth with ASD are at greatly increased risk for being diagnosed with one or more comorbid anxiety disorders. Unfortunately, most clinicians well-versed in working with youth on the spectrum are not trained in diagnosing or treating anxiety disorders; conversely, mental health practitioners often are not experienced or comfortable treating youth with ASD. This presentation will describe reasons for the increased incidence of anxiety disorders among youth with ASD, identify barriers to treatment unique to anxious youth with ASD, and provide specific evidence-based techniques for addressing anxiety symptoms among youth with ASD.
As a result of this activity, participants will be able to describe the increased rates (and hypotheses for this increase) of anxiety disorders among youth with ASD.
- Describe the increased rates (and hypotheses for this increase) of anxiety disorders among youth with ASD.
- List and explain specific treatment barriers unique to anxious youth with ASD.
- List and describe evidence-based modifications to treatment of anxious youth with ASD.
This session is approved for .15 ASHA and 1.5 APA CEs. Program content focuses on topics related to psychological practice, education, or research other than application of psychological assessment and/or intervention methods that are supported by contemporary scholarship grounded in established research procedures by providing professionals with evidence based techniques and resources about ASD, and how to best support their patients and families to make thoughtful decisions. This training agenda will emphasize diagnosis, interventions across the lifespan, medical perspectives, research initiatives, and family support.